Version 2 2024-03-12, 18:00Version 2 2024-03-12, 18:00
Version 1 2024-03-01, 11:34Version 1 2024-03-01, 11:34
journal contribution
posted on 2024-03-12, 18:00authored byAbhishek Iyer, Annemieke Madder, Ishwar Singh
<p>“This represents the first invivo evidence for the therapeutic potential of simplified synthetic teixobactins in their ability to significantly mitigate bacteria linfections and associated severities”</p>